rac-tert-Butyl 4-(2-Chloro-4-fluorophenyl)-5-cyano-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate

ID: ALA1094114

PubChem CID: 46237842

Max Phase: Preclinical

Molecular Formula: C19H20ClFN2O2

Molecular Weight: 362.83

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1=C(C#N)C(c2ccc(F)cc2Cl)C(C(=O)OC(C)(C)C)=C(C)N1

Standard InChI:  InChI=1S/C19H20ClFN2O2/c1-10-14(9-22)17(13-7-6-12(21)8-15(13)20)16(11(2)23-10)18(24)25-19(3,4)5/h6-8,17,23H,1-5H3

Standard InChI Key:  MPFVEJCVRPLSQN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 26  0  0  0  0  0  0  0  0999 V2000
    6.9527   -4.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9516   -5.1982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6664   -5.6110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3828   -5.1977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3800   -4.3672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6646   -3.9580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6667   -6.4311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9504   -6.8421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9482   -7.6635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6607   -8.0801    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3771   -7.6690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3810   -6.8414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2321   -8.0732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0901   -8.0841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0960   -6.4298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2370   -6.4278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2392   -5.6028    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5214   -6.8384    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8080   -6.4240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0925   -6.8346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8102   -5.5990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0875   -6.0083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6621   -3.1330    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.8083   -6.0125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0980   -5.6091    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  3  7  1  0
  6  1  1  0
  9 13  1  0
  7  8  1  0
 11 14  1  0
  1  2  2  0
 12 15  1  0
  3  4  2  0
  8 16  1  0
 16 17  2  0
  4  5  1  0
 16 18  1  0
  2  3  1  0
 18 19  1  0
  5  6  2  0
 19 20  1  0
  7 12  1  0
 19 21  1  0
  8  9  2  0
 19 22  1  0
  9 10  1  0
  6 23  1  0
 10 11  1  0
 15 24  3  0
 11 12  2  0
  4 25  1  0
M  END

Associated Targets(Human)

NR3C2 Tclin Mineralocorticoid receptor (2134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cacna1c Voltage-gated L-type calcium channel (1164 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 362.83Molecular Weight (Monoisotopic): 362.1197AlogP: 4.58#Rotatable Bonds: 2
Polar Surface Area: 62.12Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.52CX LogD: 3.52
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -1.45

References

1. Arhancet GB, Woodard SS, Dietz JD, Garland DJ, Wagner GM, Iyanar K, Collins JT, Blinn JR, Numann RE, Hu X, Huang HC..  (2010)  Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines.,  53  (10): [PMID:20408553] [10.1021/jm1002827]
2. Arhancet GB, Woodard SS, Iyanar K, Case BL, Woerndle R, Dietz JD, Garland DJ, Collins JT, Payne MA, Blinn JR, Pomposiello SI, Hu X, Heron MI, Huang HC, Lee LF..  (2010)  Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists.,  53  (16): [PMID:20672820] [10.1021/jm100506y]

Source